Status sent from the Pharmacy Department at a university hospital in Incheon

1.     Anticancer drug robot (reviewed in July 2018)

1)     Low cost effectiveness compared to the number of anticancer drugs at the hospital

2)     Difficult to use due to insufficient space for equipment installation and air-conditioning facilities

2.     CSTD (Closed Drug Delivery Device) Test (Reviewed Jan. 2021)

1)     Absence of classification criteria by the Ministry of Food and Drug Safety for the product concerned, cost cannot be calculated (Should be treated as hospital consumption cost when using)

At the time of the review, the anticancer drug robot was used when the number of prescriptions increased and space was prepared, and the CSTD was supposed to re-examine once the payroll was applied.

The above is an email given by the head of the pharmaceutical department of the hospital based on the data provided by the company, and it is the situation of most hospitals in Korea.

All medical institutions around the world, such as the amount of dispensing, the range, the price, and the need for additional facilities, so our ACPi system is an optimized equipment and system.

Thank you.